Thursday, December 11, 2014

QUESTIONS FOR ASSESSMENT OF QUALITY OF TABLETS AND CAPSULES

1) What are the objectives of the tests for uniformity of diameter and uniformity of content?
-The objectives of the tests for uniformity of diameter are to increase the patient compliance by increasing the quality of product appearance and also to prevent any confusion towards the patient about the dosage of the medications. The objectives of the tests for uniformity of content are to ensure uniform dosage supplied to the patient and prevent from overdose cases due to non-uniform amount of active ingredients in the capsules or tablets.


2) State the types of tablets and capsules that must be tested for the uniformity of diameter and uniformity of content.
- Uniformity of diameter was introduced by the BP in 1958 to remove doubt. Uniformity of diameter tests involves all the uncoated and coated tablets and it is not applicable for the enteric tablets, film-coated tablets and sugar-coated tablets. For uniformity of content tests, it involves all tablets.

3) Give reasons for the non-compliance to test for uniformity of weight.
-The reasons for non-compliance to test for uniformity of weight are uneven feeding of granules into the die and due to irregular movement of the lower punch that cause variation in capacity die space.

4)  Why does dissolution test suitable to be used for batch to batch quality control?
- Drug absorption from a solid dosage form after oral administration depends on the release of the drug substance from the drug product, the dissolution or solubilization of the drug under physiological conditions, and the permeability across the gastrointestinal tract. Because of the critical nature of the first two of these steps, in vitro dissolution may be relevant to the prediction of in vivo performance. Based on this general consideration, in vitro dissolution tests for immediate release solid oral dosage forms, such as tablets and capsules, are used to assess the batch to batch quality of a drug product.

5. Explain the difference found in the procedure for dissolution test in the United States Pharmacopoeia and the British Pharmacopoeia.
- In United States Pharmacopoiea (USP) only involved 4 types of apparatus which are basket type, paddle type, reciprocating cylinder, flow through cell types; whereas British Pharmacopoeia (BP) involves 3 apparatus which are basket type, paddle type, and flow through cell type. Besides that, for testing in conventional-released dosage forms, in USP the thermometer is removed after dissolution medium is equilibrate to 37°C °C, whereas in BP, the test may also be carried out with the thermometer in place, provided it is shown that results equivalent to those obtained without the thermometer are obtained. The difference in the procedure found in USP and BP could be due to the different standard of level of dissolution set by the regulation of different countries. Besides that, the linearity of the test conducted by both countries may be different

No comments:

Post a Comment